Pharmaceutical Industry Making Adjustments to Include Patient Perspective across Medical and Commercial Operations
CHAPEL HILL, N.C., March 6, 2015 /PRNewswire/ -- Patient-oriented programs have risen in importance within the pharmaceutical industry as regulators and payers have placed more emphasis on patient outcomes and consumers have taken a more active role in their healthcare decisions.
Across the industry, organizations are embracing patient centricity (as the trend has been labeled in pharma).
You don't have to look any further than last year when Sanofi appointed a Chief Patient Officer to its executive ranks or when Takeda Pharmaceutical Co. announced a reorganization that the global company's president said was designed to ensure there was "...greater proximity to the patients and our customers in order to truly understand their needs and respond appropriately."
With regulators and payers pushing for better health outcomes, pharma understands its business model needs to generate better results, both clinically and economically. Thus, pharma companies large and small are focusing on becoming more patient-oriented across their operations to make sure they are providing products and services that improve health.
Best Practices, LLC conducted a primary research project at the end of 2014 to capture the current state of affairs in pharma's move to patient centricity. The resulting report, "Patient Support Excellence: Structure, Activities and Resource Levels to Ensure Patient-Centric Products and Services," produced reliable industry metrics on current patient support group structure, resource levels, activities and partners.
The research illustrates:
- How companies are organizing their patient support groups
- What patient support activities have the most value
- What budgetary and staffing resources are present at other companies' patient groups
- Which external organizations are best partners for patient-oriented activities
- How effective organizations are at engaging patients in company programs
Leaders working in patient-oriented roles can use this study to evaluate how their patient engagement programs stack up against industry averages and trends.
Best Practices, LLC engaged 19 Patient Support leaders from 19 pharmaceutical companies through a benchmarking survey. Research analysts also conducted secondary research regarding different ways companies are engaging with patients.
To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1335.htm.
For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking and advisory services firm serving pharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and most of the top 50 pharmaceutical companies. The firm conducts primary research and uses its comprehensive benchmarking tools and executives interviews to form the basis for our Benchmarking Reports and advisory services utilized by top executives. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
SOURCE Best Practices, LLC
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article